MoonLake Immunotherapeutics (MLTX)

NASDAQ: MLTX · IEX Real-Time Price · USD
27.21
-0.68 (-2.44%)
At close: May 31, 2023, 4:00 PM
27.07
-0.14 (-0.51%)
After-hours: May 31, 2023, 7:39 PM EDT

Income Statement (Annual)

Millions USD. Fiscal year is Jan - Dec.
Year 202220212020
Selling, General & Admin
23.0118.040.11
Research & Development
42.0535.530
Other Operating Expenses
000
Operating Expenses
65.0653.580.11
Operating Income
-65.06-53.58-0.11
Other Expense / Income
-0.590.06-0.01
Pretax Income
-64.47-53.64-0.09
Income Tax
0.0400
Net Income
-64.51-53.64-0.09
Shares Outstanding (Basic)
292339
Shares Outstanding (Diluted)
292339
Shares Change
-87.40%2510.73%-
EPS (Basic)
-1.70-230.15-0.01
EPS (Diluted)
-1.70-230.15-0.01
Free Cash Flow Per Share
-1.90-0.15-0.04
EBITDA
-64.46-53.63-0.09
Depreciation & Amortization
0.0100
EBIT
-64.47-53.64-0.09
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).